The lab in Los Angeles billed for tests that were never ordered by doctors who never knew

The letter sat on Dr. Marisol's desk for three days before she opened it.

She is fifty-four. She runs a two-doctor internal medicine practice in a town small enough that the receptionist knows which patients take their coffee black on the way out. The envelope was from a billing auditor she had never heard of, in a state she had not visited in twenty years. She assumed it was junk. The kind of thing the office burns through in a shredder on Fridays.

When she finally opened it, she read the first paragraph twice.

The auditor wanted to know why she had ordered roughly nine thousand multi-panel respiratory tests for patients in California between August 2023 and June 2025. COVID. Flu A and B. RSV. Patients she had never seen. Patients whose names she did not recognize. The orders carried her National Provider Identifier. Her signature, in a font that was not her signature. Her license number, correct down to the last digit.

She set the letter down. She did not call her lawyer right away. She sat in the chair and tried to remember if she had ever lost a prescription pad.

She had not lost a prescription pad. The pad was not how they got in.

I.

This is a story about a laboratory in Los Angeles called Golden Star Labs, and the man who owned it, and the doctors who did not know their names were the keys to the door.

On Tuesday, June 24, 2026, James Shuford Price III, fifty-nine, of Raleigh, North Carolina, pleaded guilty in federal court in the Eastern District of North Carolina to paying illegal kickbacks for healthcare referrals and to filing a false federal tax return for 2022. According to the Department of Justice, between August 2023 and June 2025, Golden Star Labs submitted more than eighty-five million dollars in false claims to Medi-Cal, the California Medical Assistance Program, and more than eleven million dollars in false claims to Medicare. Those programs paid out over sixty million dollars before anyone pulled the plug.

A multi-panel respiratory test is what it sounds like. You swab a person's nose. The lab runs the sample for COVID, flu, and RSV. The lab bills the patient's insurance. If the patient is on Medi-Cal or Medicare, the bill goes to the government. The government pays the lab. The lab keeps the money.

That is the legitimate version.

The version the plea describes works differently. Price's lab paid people called "collectors" to bring in specimens. The plea says GSL paid over seventeen million dollars in kickbacks to those collectors between August 2023 and January 2025, and the kickbacks were tied to the volume of samples produced. More swabs, more money. That is a kickback under federal law because the payment is for the referral itself, not for any service the collector legitimately performed.

A kickback. That is the word the statute uses. The plainer word is bribe.

II.

Picture the collector's car. A trunk full of swab kits in plastic bags, somewhere in a parking lot outside a senior center or a soup kitchen or a homeless encampment in Los Angeles. The collector counts the bags. The collector calls in the count. The collector gets paid by the bag.

That is the supply side.

The demand side is the requisition. Every lab test billed to Medi-Cal or Medicare has to be ordered by a clinician. A doctor, a nurse practitioner, a physician assistant. Somebody with the legal authority to say this person needs this test. Without the order, there is no bill. Without the bill, there is no money.

Price did not have a clinician. He had a problem.

According to the DOJ's account of the plea, Golden Star Labs solved the problem by using stolen clinician identifiers to manufacture the orders. In the first six months of the scheme, the plea states, approximately ninety-six percent of GSL's Medi-Cal claims relied on fraudulent test authorizations tied to a single out-of-state physician whose identity had been stolen. One doctor. One license number. Tens of thousands of orders.

Read that slowly.

Later, from late March 2024 through January 2025, about ninety-two percent of GSL's Medi-Cal claims relied on the stolen credentials of five different clinicians.

Five names. Five license numbers. Most of the money.

This is what the requisition mill looks like from the outside. Stolen signatures in. Federal dollars out.

III.

In February 2024, according to the plea, Price purportedly paused GSL's testing operations to "clean up" billing issues. The lab went quiet for a month. The lights stayed on. The accountants did whatever accountants do when a CEO tells them the words "clean up."

In March 2024, the lab resumed the same practices.

That is the part that may be the saddest. Not the fraud itself. The pause. The moment somebody on the inside knew enough to stop, and stopped, and then started again.

To make the resumed operation appear legal, the plea states, Price directed his staff to create fake contracts with the collectors. The contracts specified fixed fees. The contracts prohibited volume-based payments. The contracts were the paperwork a regulator would ask for.

The cash kept paying per sample.

The contract was the costume. The cash was the body.

IV.

Dr. Marisol is not a real person. She is built from the description in the DOJ release of clinicians whose credentials were used without their knowledge. The real doctors at the center of this case have not been named publicly, and there is a reason for that. Their license numbers are still active. Their patients still trust them. The harm done to them is harder to put on a balance sheet than the harm done to Medi-Cal.

But the letter is real. Some version of it landed on some real doctor's desk. Probably more than one.

Imagine sitting with that letter. Imagine the math the doctor has to do. How many of her real patients in the last two years might have a flag on their chart because her number is in a federal database tied to fraud. How long it will take to prove she did not do it. How many depositions. How many hours with a lawyer she did not budget for. Whether her malpractice carrier will renew. Whether the hospital where she has privileges will quietly stop sending her referrals while it waits for the dust to settle.

The lab in Los Angeles made the money. The doctor in the small town pays the cleanup bill in time and reputation.

That is also part of the machine. The cost was distributed. The profit was not.

V.

The numbers, laid out in the order the plea presents them, are their own argument.

Over $85M in false claims to Medi-Cal.

Over $11M in false claims to Medicare.

Over $60M paid out.

Over $17M in kickbacks.

Over $6M in assets seized by the FBI and the U.S. Attorney's Office during the investigation.

Price also admitted to failing to report income from multiple sources on his 2022 federal income tax return, including, according to the plea, money from a prior investment scam. The plea does not detail the prior scam. That sentence sits in the record like a door the public has not been allowed through yet.

A statutory maximum of thirteen years in prison. A $500,000 fine. Three years of supervised release. Restitution to Medi-Cal, the Centers for Medicare and Medicaid Services, the IRS, and others to be determined at sentencing.

U.S. Attorney Ellis Boyle, in the DOJ release, called it "lowdown, dirty pool." FBI Special Agent in Charge Reid Davis called it "a profound violation of public trust." Those are the public lines. They are the closing arguments the case will be remembered by.

The line that does the most work is buried lower. The IRS's Donald "Trey" Eakins talked about protecting patients and clinicians. Patients and clinicians. Not just taxpayers. The people whose names were used.

VI.

Here is what the machine looks like with the cover off.

A lab. A billing system. A list of stolen clinician identifiers. A network of collectors paid per swab. A government program with a check-writing process designed to be fast, because in 2023 and 2024 the country wanted respiratory tests fast. A pause to "clean up." A restart. A drawer full of contracts that said one thing while the cash did another.

The pandemic emergency programs were built to move money quickly to legitimate labs doing real testing. Speed was the feature. Verification was the trade-off. Price's plea, as the DOJ describes it, is what happens when somebody figures out that the verification is the seam.

He is not the first. The 2026 National Health Care Fraud Takedown referenced in the DOJ materials includes a long list of similar pleas and indictments. Different cities. Different lab names. Same shape. Stolen credentials, paid collectors, government reimbursement, a holding company in a different state.

Golden Star Labs is the name that closed this week. The shape is older. The shape is reusable.

VII.

Dr. Marisol's letter is on her desk again. She has read it eight times.

She is going to be fine. Eventually. Her lawyer will write the response. The auditor will accept that the orders were fraudulent. Her license will stay clean. Her practice will keep running. Most of her patients will never know any of this happened.

But every time she signs a prescription for the next year, she will pause for half a second longer than she used to. She will wonder if her signature is on something she has not seen. She will wonder how she would know.

That is the cost the plea agreement does not measure.

Price pleaded guilty in Raleigh on a Tuesday. The lab in Los Angeles had been billing for almost two years by then. The doctors whose names were on the orders found out last.